Related references
Note: Only part of the references are listed.Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria
Elena Marshall et al.
EYE (2021)
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Michelle Petri et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study
Lavanya Mittal et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
David J. Browning et al.
CLINICAL OPHTHALMOLOGY (2018)
Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine
Ji-Won Kim et al.
JOURNAL OF RHEUMATOLOGY (2017)
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Michael F. Marmor et al.
OPHTHALMOLOGY (2016)
Pericentral Retinopathy and Racial Differences in Hydroxychloroquine Toxicity
Ronald B. Melles et al.
OPHTHALMOLOGY (2015)
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
M. Jallouli et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Effect of Disease Stage on Progression of Hydroxychloroquine Retinopathy
Michael F. Marmor et al.
JAMA OPHTHALMOLOGY (2014)
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
Ronald B. Melles et al.
JAMA OPHTHALMOLOGY (2014)
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
Nathalie Costedoat-Chalumeau et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Share Paper
